...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.
【24h】

Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.

机译:评估VITEK 2 AST-N111卡与ESBL Etest和组合磁盘方法相比,可检测大肠埃希菌,肺炎克雷伯菌和产氧克雷伯菌中的广谱β-内酰胺酶(ESBL)。

获取原文
获取原文并翻译 | 示例
           

摘要

The VITEK 2 AST-N111 card was evaluated for detection of extended-spectrum beta-lactamases (ESBLs) by testing 51 ESBL positive and 50 ESBL negative isolates of E. coli, K. pneumoniae, and K. oxytoca. The occurrence of beta-lactamase genes was confirmed by PCR and sequencing. The advanced expert system (AES) of the VITEK 2 system achieved sensitivity and specificity values of 100% and 96.0%, respectively. The ESBL test of the VITEK 2 AST-N111 card showed a sensitivity of 92.1% and a specificity of 90.0%. Contradictory results obtained with the two VITEK 2 tools could be clarified by combination disk tests in nine of 11 isolates. The combined use of AES and ESBL tests of the AST-N111 card in association with combination disk tests in case of contradictory results seems to be a reliable method for ESBL detection.
机译:通过测试51株ESBL阳性,50株ESBL阴性的大肠杆菌,肺炎克雷伯菌和产氧克雷伯菌,对VITEK 2 AST-N111卡进行了广谱β-内酰胺酶(ESBLs)检测。通过PCR和测序证实了β-内酰胺酶基因的出现。 VITEK 2系统的高级专家系统(AES)的灵敏度和特异性值分别达到100%和96.0%。 VITEK 2 AST-N111卡的ESBL测试显示灵敏度为92.1%,特异性为90.0%。通过在11个分离物中的9个中进行组合磁盘测试,可以证明使用两个VITEK 2工具获得的矛盾结果。在结果矛盾的情况下,结合使用AST-N111卡的AES和ESBL测试以及磁盘组合测试似乎是一种可靠的ESBL检测方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号